SHAREHOLDERS' EQUITY (Tables)

12 Months Ended

Dec. 31, 2023

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Schedule of Stock Option Activity

	Year ended December 31,
	2023			2022			2021
Risk free interest		3.57%-4.58	%		1.41%-4.15	%		0.26%-1.14	%
Dividend yields		0	%		0	%		0	%
Volatility		52.77%-53.87	%		51.45%-52.95	%		41.09%-50.62	%
Expected term (in years)		3.85-3.92			3.92-4.00			4.00-4.04

Schedule of Stock-Based Compensation Expenses

	Number of options			Weighted-average exercise price		Weighted- average remaining contractual term (in years)		Aggregate intrinsic value (in thousands)
Outstanding at January 1, 2023		3,441,644		$	8.1		4.1	$	80
Granted		2,807,500		$	5.9
Exercised		(97,268	)	$	5.3
Forfeited and cancelled		(472,101	)	$	9.9
Outstanding as of December 31, 2023		5,679,775		$	6.9		4.2	$	817
Exercisable as of December 31, 2023		1,562,275		$	8.0		2.8	$	55

Schedule of Stock Option Activity by Exercise Price

	Year ended December 31,
	2023		2022		2021
Cost of revenues of products	$	185	$	147	$	137
Cost of revenues of services		222		146		140
Research and development expenses, net		654		427		304
Selling and marketing expenses		417		456		422
General and administrative expenses		1,945		1,044		301
	$	3,423	$	2,220	$	1,304